Your browser doesn't support javascript.
loading
APOE ε4 carriage associates with improved myocardial performance from adolescence to older age.
Topriceanu, Constantin-Cristian; Shah, Mit; Webber, Matthew; Chan, Fiona; Shiwani, Hunain; Richards, Marcus; Schott, Jonathan; Chaturvedi, Nishi; Moon, James C; Hughes, Alun D; Hingorani, Aroon D; O'Regan, Declan P; Captur, Gabriella.
Afiliación
  • Topriceanu CC; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
  • Shah M; UCL Institute of Cardiovascular Science, University College London, London, UK.
  • Webber M; Cardiac MRI Unit, Barts Heart Centre, London, UK.
  • Chan F; Cardiology Department, Centre for Inherited Heart Muscle Conditions, The Royal Free Hospital, Pond Street, Hampstead, London, UK.
  • Shiwani H; Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
  • Richards M; MRC London Institute of Medical Science, Imperial College London, London, UK.
  • Schott J; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
  • Chaturvedi N; UCL Institute of Cardiovascular Science, University College London, London, UK.
  • Moon JC; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
  • Hughes AD; UCL Institute of Cardiovascular Science, University College London, London, UK.
  • Hingorani AD; UCL Institute of Cardiovascular Science, University College London, London, UK.
  • O'Regan DP; Cardiac MRI Unit, Barts Heart Centre, London, UK.
  • Captur G; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
BMC Cardiovasc Disord ; 24(1): 172, 2024 Mar 21.
Article en En | MEDLINE | ID: mdl-38509472
ABSTRACT

BACKGROUND:

Although APOE ε4 allele carriage confers a risk for coronary artery disease, its persistence in humans might be explained by certain survival advantages (antagonistic pleiotropy).

METHODS:

Combining data from ~ 37,000 persons from three older age British cohorts (1946 National Survey of Health and Development [NSHD], Southall and Brent Revised [SABRE], and UK Biobank) and one younger age cohort (Avon Longitudinal Study of Parents and Children [ALSPAC]), we explored whether APOE ε4 carriage associates with beneficial or unfavorable left ventricular (LV) structural and functional metrics by echocardiography and cardiovascular magnetic resonance (CMR).

RESULTS:

Compared to the non-APOE ε4 group, APOE ε4 carriers had similar cardiac phenotypes in terms of LV ejection fraction, E/e', posterior wall and interventricular septal thickness, and LV mass. However, they had improved myocardial performance resulting in greater LV stroke volume generation per 1 mL of myocardium (higher myocardial contraction fraction). In NSHD (n = 1467) and SABRE (n = 1187), ε4 carriers had a 4% higher MCF (95% CI 1-7%, p = 0.016) using echocardiography. Using CMR data, in UK Biobank (n = 32,972), ε4 carriers had a 1% higher MCF 95% (CI 0-1%, p = 0.020) with a dose-response relationship based on the number of ε4 alleles. In addition, UK Biobank ε4 carriers also had more favorable radial and longitudinal strain rates compared to non APOE ε4 carriers. In ALSPAC (n = 1397), APOE ε4 carriers aged < 24 years had a 2% higher MCF (95% CI 0-5%, p = 0.059).

CONCLUSIONS:

By triangulating results in four independent cohorts, across imaging modalities (echocardiography and CMR), and in ~ 37,000 individuals, our results point towards an association between ε4 carriage and improved cardiac performance in terms of LV MCF. This potentially favorable cardiac phenotype adds to the growing number of reported survival advantages attributed to the pleiotropic effects APOE ε4 carriage that might collectively explain its persistence in human populations.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Apolipoproteína E4 Límite: Adolescent / Aged / Child / Humans Idioma: En Revista: BMC Cardiovasc Disord Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Apolipoproteína E4 Límite: Adolescent / Aged / Child / Humans Idioma: En Revista: BMC Cardiovasc Disord Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido